Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor

Cell

Volumn 111, Issue 2, 2002, Pages 219-230

  Lee, Frank J S ^a   Xue, Sheng ^a   Pei, Lin ^a   Vukusic, Brian ^a   Chéry, Nadege ^a   Wang, Yushan ^b   Wang, Yu Tian ^b   Niznik, Hyman B ^a   Yu, Xian min ^a   Liu, Fang ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR SUBUNIT;

ARTICLE; BRAIN NERVE CELL; HIPPOCAMPUS; ION CURRENT; NERVE CELL CULTURE; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 18644386370     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00962-5     Document Type: Article

References (47)

1. Blank T., Nijholt I., Teichert U., Kugler H., Behrsing H., Fienberg A., Greengard P., Spiess J. The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc. Natl. Acad. Sci. USA. 94:1997;14859-14864.
2. Bourne H.R. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9:1997;134-142.
3. Brorson J.R., Marcuccilli C.J., Miller R.J. Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke. 26:1995;1259-1266.
4. Cepeda C., Levine M.S. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev. Neurosci. 20:1998;1-18.
5. Cepeda C., Buchwald N.A., Levine M.S. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. USA. 90:1993;9576-9580.
6. Choi D.W. Calcium. still center-stage in hypoxic-ischemic neuronal death Trends Neurosci. 18:1995;58-60.
7. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51:1999;7-61.
8. 2+ in cell physiology and patho-physiology. Cell Calcium. 28:2000;339-348.
9. Egea J., Espinet C., Soler R.M., Dolcet X., Yuste V.J., Encinas M., Iglesias M., Rocamora N., Comella J.X. Neuronal survival induced by neurotrophins requires calmodulin. J. Cell Biol. 154:2001;585-597.
10. Ehlers M.D., Zhang S., Bernhadt J.P., Huganir R.L. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell. 84:1996;745-755.
11. Feldman D.S., Zamah A.M., Pierce K.L., Miller W.E., Kelly F., Rapacciuolo A., Rockman H.A., Koch W.J., Luttrell L.M. Selective inhibition of heterotrimeric Gs signaling. targeting the receptor-G protein interface using a peptide minigene encoding the Gα s carboxyl terminus J. Biol. Chem. 29:2002;29-35.
12. Fischer R., Julsgart J., Berchtold M.W. High affinity calmodulin target sequence in the signalling molecule PI 3-kinase. FEBS Lett. 425:1998;175-177.
13. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α Science. 283:1999;393-397.
14. Gines S., Hillion J., Torvinen M., Le Crom S., Casado V., Canela E.I., Rondin S., Lew J.Y., Watson S., Zoli M.et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. USA. 97:2000;8606-8611.
15. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
16. Greengard P. The neurobiology of slow synaptic transmission. Science. 297:2001;1024-1030.
17. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5:2002;405-414.
18. Harvey J., Lacey M.G. A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J. Neurosci. 17:1997;5271-5280.
19. Hawes B.E., Luttrell L.M., Exum S.T., Lefkowitz R.J. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J. Biol. Chem. 269:1994;15776-15785.
20. Joyal J.L., Burks D.J., Pons S., Matter W.F., Vlahos C.J., White M.F., Sacks D.B. Calmodulin activates phosphatidylinositol 3-kinase. J. Biol. Chem. 272:1997;28183-28186.
21. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
22. Lamey M., Thompson M., Varghese G., Chi H., Sawzdargo M., George S.R., O'Dowd B.F. Distinct residues in the carboxyl tail mediate agonist induced desensitization and internalization of the human dopamine D1 receptor. J. Biol. Chem. 277:2002;9415-9421.
23. Lezcano N., Mrzljak L., Eubanks S., Levenson R., Goldman-Rakic P., Bergson C. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science. 287:2000;1660-1664.
24. Lee F.J.S., Liu F., Pristupa Z.B., Niznik H.B. Direct binding and functional coupling of α-synuclein to the dopamine transporter. FASEB J. 15:2001;916-926.
25. Lei G., Xue S., Chéry N., Liu Q., Xu J.-D., Kwan C.L., Fu Y.P., Lu Y.M., Liu M.Y., Harder K.W., Yu X.-M. Gain control of n-methyl-d-aspartate receptor activity by receptor-like protein tyrosine phosphatase α EMBO. 21:2002;2977-2989.
26. Levine M.S., Altemus K.L., Cepeda C., Cromwell H.C., Crawford C., Ariano M.A., Drago J., Sibley D.R., Westphal H. Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice. J. Neurosci. 16:1996;5870-5882.
27. Lieberman D.N., Mody I. Regulation of NMDA channel function by endogenous Ca (2+)-dependent phosphatase. Nature. 369:1994;235-239.
28. Lipton S.A., Nicotera P. Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium. 23:1998;165-171.
29. Liu F., Wan Q., Pristupa Z.B., Yu X.M., Wang Y.T., Niznik H.B. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature. 403:2000;274-280.
30. Man H.Y., Lin J.W., Ju W.H., Ahmadian G., Liu L., Becker L.E., Sheng M., Wang Y.T. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron. 25:2000;649-662.
31. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors. from structure to function Physiol. Rev. 78:1998;189-225.
32. Pelkey K.A., Askalan R., Paul S., Kalia L.V., Nguyen T.H., Pitcher G.M., Salter M.W., Lombroso P.J. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron. 34:2002;127-138.
33. Roche K.W., Tingley W.G., Huganir R.L. Glutamate receptor phosphorylation and synaptic plasticity. Curr. Opin. Neurobiol. 4:1994;383-388.
34. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., Patel Y.C. Receptors for dopamine and somatostatin. formation of hetero-oligomers with enhanced functional activity Science. 288:2000;154-157.
35. Rosenmund C., Westbrook G.L. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron. 10:1993;805-814.
36. Sattler R., Charlton M.P., Hafner M., Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 71:1998;2349-2364.
37. Sattler R., Xiong Z., Lu W.Y., MacDonald J.F., Hafner M., Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 284:1999;1845-1848.
38. Sheng M. Molecular organization of the postsynaptic specialization. Proc. Natl. Acad. Sci. USA. 98:2001;7058-7061.
39. Snyder G.L., Fienberg A.A., Huganir R.L., Greengard P. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18:1998;10297-10303.
40. Sunahara R.K., Guan H.C., O'Dowd B.F., Seeman P., Laurier L.G., Ng G., George S.R., Torchia J., Van Tol H.H., Niznik H.B. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature. 350:1991;614-619.
41. Toker A., Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 387:1997;673-676.
42. Wang L.Y., Orser B.A., Brautigan D.L., MacDonald J.F. Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature. 369:1994;230-232.
43. Westphal R.S., Tavalin S.J., Lin J.W., Alto N.M., Fraser I.D., Langeberg L.K., Sheng M., Scott J.D. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 285:1999;93-96.
44. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A.H., Craig A.M., Sheng M. Competitive binding of α-actinin and calmodulin to the NMDA receptor. Nature. 385:1997;439-442.
45. Yu X.M., Askalan R., Keil G.J. 2nd, Salter M.W. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 275:1997;674-678.
46. Yu X.-M., Salter M.W. The gain control of NMDA receptor mediated synaptic currents by intracellular sodium. Nature. 396:1998;469-474.
47. Zeevalk G.D., Schoepp D., Nicklas W.J. Aurintricarboxylic acid prevents NMDA-mediated excitotoxicity. evidence for its action as an NMDA receptor antagonist J. Neurochem. 61:1993;386-389.